Si, L., Wang, J., Mao, L., Du, Y., Gu, J., Wei, X., Li, C., Dai, J., Cui, C., Lian, B., Yan, X., Wang, X., Tang, B., Li, S., Chi, Z., Zhou, L., Sheng, X., Guo, J. (2026). Adjuvant DC-CIK plus high-dose interferon-α versus high-dose interferon-α alone in resected stage IIB–IIID melanoma: A propensity score–matched real-world study with long-term follow-up.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e21536